ACP promoter

Abstract

Isolated nucleotide sequences encoding a promoter of the Acyl Carrier Protein (“ACP”).

Description

The present application is related to U.S. Non-Provisional patent application Ser. No. 12/706,683 filed on Feb. 16, 2010, and issued as U.S. Pat. No. 8,314,228 on Nov. 20, 2012, titled Bidirectional Promoters in Nannochloropsis,” which is hereby incorporated by reference.

The present application is related to U.S. Non-Provisional patent application Ser. No. 12/480,635 filed on Jun. 8, 2009, and issued as U.S. Pat. No. 8,318,482 on Nov. 27, 2012, titled “VCP-Based Vectors for Algal Cell Transformation,” which is hereby incorporated by reference.

REFERENCE TO SEQUENCE LISTINGS

The present application is filed with sequence listing(s) attached hereto and incorporated by reference.

BACKGROUND OF THE INVENTION

Field of the Invention

This invention relates to molecular biology, and more specifically, to algal promoters.

SUMMARY OF THE INVENTION

Isolated nucleotide sequences encoding a promoter of the Acyl Carrier Protein (“ACP”).

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 illustrates an exemplary NT7 transformation construct.

FIG. 2 illustrates an ACP promoter—sh ble gene—3′ untranslated region transformation construct.

FIG. 3 illustrates a VCP promoter—sh ble gene—3′ untranslated region—ACP promoter transformation construct (“ACP activator construct”).

FIGS. 4A-4E illustrates the VCP promoter—sh ble gene—3′ untranslated region—ACP promoter transformation construct (“ACP activator construct”) and transformation results when the construct is used under various exemplary situations.

FIG. 5 shows the nucleotide sequence of an ACP gene in the Nannochloropsis genome (SEQ ID NO:1).

FIG. 6 shows the nucleotide sequence an ACP gene transcript as predicted by transcriptome analysis (SEQ ID NO:2).

FIG. 7 shows the nucleotide sequence of the ACP promoter when amplified by the P525 and P526 primers (SEQ ID NO:3).

FIG. 8 shows the nucleotide sequence of the sh ble gene—3′ untranslated region as amplified by the P113 and P266 primers. The sh ble gene—3′ untranslated region represents part of the NT7 transformation construct as illustrated in FIG. 1 (SEQ ID NO:4).

FIG. 9 shows the nucleotide sequence of the ACP promoter—sh ble gene—3′ untranslated region transformation construct as illustrated in FIG. 2 (SEQ ID NO:5).

FIG. 10 shows the nucleotide sequence of the ACP promoter when amplified by the P563 and P564 primers (SEQ ID NO:6).

FIG. 11 shows the nucleotide sequence of the NT7 transformation construct of FIG. 1 when amplified by the P215 and P266 primers (SEQ ID NO:7).

FIG. 12 shows the nucleotide sequence of the ACP activator construct as illustrated in FIG. 3 that was generated by fusing SEQ ID NO:6 and SEQ ID NO:7 with the primers P564 and P215 (SEQ ID NO:8).

FIG. 13 shows the nucleotide sequences of primers:

P525 (SEQ ID NO:9);

P526 (SEQ ID NO:10);

P563 (SEQ ID NO:11);

P564 (SEQ ID NO:12);

P113 (SEQ ID NO:13);

P215 (SEQ ID NO:14); and

P266 (SEQ ID NO:15).

FIG. 14 shows the nucleotide sequence of the ACP promoter (SEQ ID NO:16).

DETAILED DESCRIPTION OF THE INVENTION

Identified herein is a new strong promoter for the expression of genes in Nannochloropsis.

The Acyl Carrier Protein (“ACP”) is a protein used in various metabolic processes, such as in fatty acid biosynthesis. Whole transcriptome analysis of log phase growth cultures and cultures growing under Nitrogen starvation revealed a very high expression of this small protein. High transcript representation under either of these conditions prompted the inventors to use the ACP promoter within selection markers for the transformation of Nannochloropsis.

FIG. 1 illustrates an exemplary NT7 transformation construct as illustrated and described in U.S. Non-Provisional patent application Ser. No. 12/706,683 filed on Feb. 16, 2010, and issued as U.S. Pat. No. 8,314,228 on Nov. 20, 2012, titled “Bidirectional Promoters in Nannochloropsis,” which is hereby incorporated by reference. FIG. 1 includes a VCP bidirectional promoter comprising “Prom1”, “Prom2”, a sh ble gene and the UTR of a different VCP gene (‘UTR’). The sh ble gene is from Streptoalloteichus hindustanus and confers resistance to the antibiotic Zeocin. As shown in FIG. 1, replacement of the bidirectional promoter with the ACP promoter yields the construct depicted in FIG. 2, where sh ble gene expression is driven by the ACP promoter.

FIG. 2 illustrates an ACP promoter—sh ble gene—3′ untranslated region transformation construct. The ACP promoter drives expression of the sh ble gene (that is attached to a VCP1 untranslated region) and proved to be suitable as a highly active promoter in high efficiency transformation constructs.

FIG. 3 illustrates a VCP promoter—sh ble gene—3′ untranslated region—ACP promoter transformation construct (“ACP activator construct”). The ACP activator construct comprises the second half of the bidirectional promoter (“Prom2”, as in FIG. 1), the sh ble gene, the UTR of a different VCP gene (‘UTR’) and the ACP promoter (“ACP_P”). The inventors attached the ACP promoter to existing constructs, such as the NT7 transformation construct. The NT7 construct had been truncated (first half of bidirectional promoter removed, while the other half is still present to drive expression of the sh ble gene. The ACP promoter had been added after the NT7 UTR region to the right). When fused to such a construct at the 3′ end as shown in FIG. 3, the ACP promoter acted as an activator for downstream genes when the entire construct inserted randomly into the Nannochloropsis genome. The inventors constructed an insertional activator library (>50.000 cultivars) in which genes were either randomly interrupted by insertion of the entire construct (FIG. 4C) or genes downstream of the transformation construct were activated (i.e. transcription of downstream genes enhanced by the strong ACP promoter FIG. 4D). FIG. 3 shows the actual ACP-activator construct, which is based on a truncated version of the NT7 construct from FIG. 1 (i.e., one half of the bidirectional promoter was omitted and the ACP promoter was added after the UTR region).

FIGS. 4A-4E illustrate the activator construct (VCP promoter—sh ble gene—3′ untranslated region—ACP promoter transformation construct) and transformation results when the construct is used under various exemplary situations.

An activator construct (FIG. 4A) may randomly insert into the Nannochloropsis genome (e.g. FIG. 4B) and may either interrupt a gene and thus render it dysfunctional (FIG. 4C) or insert in front of a gene (FIG. 4D) and thus enhance transcription of the gene. If insertion occurs with the ACP promoter pointing in a direction opposite the direction that a gene is expressed, transcription of such a gene could be down regulated (FIG. 4E).

FIG. 5 shows the nucleotide sequence of the ACP gene in the Nannochloropsis genome (SEQ ID NO:1). FIG. 5 shows primer P525, primer P526, the start codon of the ACP gene, Intron I, Intron II, and the stop codon of the ACP gene.

FIG. 6 shows the nucleotide sequence of an ACP gene transcript as predicted by transcriptome analysis (SEQ ID NO:2).

FIG. 7 shows the nucleotide sequence of the ACP promoter when amplified by the P525 and P526 primers (SEQ ID NO:3). FIG. 7 shows a PCR product obtained with primer P525 and primer P526. P525×P526 Polymerase Chain Reaction (“PCR”) on genomic DNA yielded a DNA fragment suitable for fusing to the sh ble gene with the respective UTR as found in NT7, as shown in SEQ ID NO:4 (as amplified by P113×P266). SEQ ID NO:3 and SEQ ID NO:4 were fused via PCR using primers P525×P266 to yield an ACP promoter—sh ble gene—3′ untranslated region transformation construct as illustrated in FIG. 2 and equivalent to SEQ ID NO:5 of FIG. 9.

FIG. 8 shows the nucleotide sequence of the sh ble gene—3′ untranslated region as amplified by the P113 and P266 primers (SEQ ID NO:4). The sh ble gene—3′ untranslated region represents part of the NT7 transformation construct of FIG. 1. FIG. 8 shows the start codon of the sh ble gene, primer P113, UTR of NT7 transformation construct (partially), and primer P266.

FIG. 9 shows the nucleotide sequence of the ACP promoter—sh ble gene—3′ untranslated region transformation construct as illustrated in FIG. 2 (SEQ ID NO:5). FIG. 9 shows primer P525, the ACP promoter, primer P113, the start codon of the sh ble gene, UTR of NT7 transformation construct (partially), and primer P266.

FIG. 10 shows the nucleotide sequence of the ACP promoter when amplified by the P563 and P564 primers (SEQ ID NO:6). P563×P564 PCR on genomic DNA yielded the same ACP promoter sequence of SEQ ID NO:3, but suitable for fusion on a partial NT7 transformation construct as evidenced by SEQ ID NO:7 as shown in FIG. 11.

FIG. 11 shows the nucleotide sequence of the NT7 transformation construct of FIG. 1 when amplified by the P215 and P266 primers (SEQ ID NO:7). As shown in FIG. 11, the second half of the bidirectional VCP promoter sequence is driving the expression of the sh ble gene.

FIG. 12 shows the nucleotide sequence of the ACP activator construct as illustrated in FIG. 3 that was generated by fusing SEQ ID NO:6 and SEQ ID NO:7 with the primers P215 and P564 (SEQ ID NO:8). FIG. 12 shows the ACP activator construct illustrated in FIG. 3.

FIG. 13 shows the nucleotide sequences of primers:

P525 (SEQ ID NO:9);

P526 (SEQ ID NO:10);

P563 (SEQ ID NO:11);

P564 (SEQ ID NO:12);

P113 (SEQ ID NO:13);

P215 (SEQ ID NO:14); and

P266 (SEQ ID NO:15).

FIG. 14 shows the nucleotide sequence of the ACP promoter (SEQ ID NO:16).

A transformation construct or vector may comprise any number of promoters, genes, and/or other nucleic acid polymers (naturally occurring or synthetic) and/or their analogs, or other compounds that do not interfere with the ability of the transformation construct to enter the algal cell or the algal genome, or to function. In some embodiments, additional nucleotides may appear in the transformation construct to facilitate or direct the insertion of the construct (or any part thereof) into a desired location in the genome.

While various embodiments have been described above, it should be understood that they have been presented by way of example only, and not limitation. Thus, the breadth and scope of a preferred embodiment should not be limited by any of the above-described exemplary embodiments.

Claims

1. A transformation vector comprising heterologous nucleic acid sequences and the nucleotide sequence comprising SEQ ID NO: 16.